MarginsXMarginsX
Home › Markets › Health Care › ELAB

PMGC Holdings Inc. (ELAB)

ELAB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.66
+5.06% on the day
Market cap
$1.3M
Nano cap
Revenue · 2025
$590K
Prior year not contiguous
Net income · 2025
-$7.7M
-1313.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1840563/000121390026035937/0001213900-26-035937-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerELAB on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2023
SEC CIK0001840563

Financials · 2025

LineValue
Revenue$590K
Net income-$7.7M
Operating incomeNot in SEC XBRL data
Net margin-1313.0%
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$5.4M
Total assets$12.9M
P/E (computed)Net income was not positive
P/S (computed)2.3×

Warning signs

Cash runway
26.5 months
$18.1M cash at June 30, 2026
Share count, 1 year
+37601.4%
2025-11-10 to 2026-11-11 · +7952256.9% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$18.1M cash; operating cash flow -$2.1M a quarter.Report 2026-06-30
Shares outstanding1,168,935 (2026-11-11); 744,121 a year earlier; 17,329,615 three years earlier. 1y figure adjusted for splits (1-for-240 overall); 3y figure adjusted for splits (1-for-1178947.368 overall).Cover page 2026-11-11
Reverse splits, 3 years6; latest 1-for-10 on 2026-08-21Source 2026-08-21
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 4 424B5 takedowns, 4 at the marketLatest 2026-04-20
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHTL International, LLC, Houston, Texas, United States; changed auditors 1 time in 24 months8-K 4.01 2024-12-23
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$1.3M-$2.9M-$2.0M$18.1M$9.1M$2.6M10-Q 2026-08-14
Q1 2026
2026-03-31
$682K-$5.0M-$3.0M$14.4M$5.3MNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
$304K-$3.0M-$1.8M$5.4M$1.3M$590K10-K 2026-03-30
Q3 2025
2025-09-30
$286K-$2.6M-$1.5M$7.7M$3.2MNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed-$562K-$1.3M$5.7MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$1.6M-$1.3M$5.4MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2024
2024-12-31
Not filed-$1.9M-$2.0M$4.0MNo debt tagsNeeds four quarters10-K 2026-03-30
Q3 2024
2024-09-30
$527K-$1.5M-$382K$6.4M$1.2M$2.4M10-Q 2024-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-1.9%
1 month-46.6%
3 months-82.4%
Year to date-99.6%
1 year-99.9%
From 52-week high-99.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
KAPAKairos Pharma Ltd.$0.4069-10.30%$1.4M
APVOAptevo Therapeutics Inc.$0.5486-7.66%$1.5M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$2.24-6.28%$1.2M
ARTLArtelo Biosciences Inc.$1.70-17.87%$1.6M
GOVXGeoVax Labs Inc.$2.02+18.48%$1.1M
ENLVEnlivex Ltd.$1.12-5.88%$1.7M
SXTP60 Degrees Pharmaceuticals Inc.$0.4938-4.65%$1.7M
HCWBHCW Biologics Inc.$0.8000+3.48%$1.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier